Nurix Therapeutics Inc (NRIX) — Capital Reinvestment Ratio

Latest as of November 2023: 0.10x

Nurix Therapeutics Inc (NRIX) has a Capital Reinvestment Ratio of 0.10x as of November 2023, meaning it reinvests 0% of its operating cash flow ($26.69 Million) in capital expenditures ($2.58 Million). See Nurix Therapeutics Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

$26.69 Million

USD

Capital Expenditures

$2.58 Million

USD

Data as of

Nov 2023

Most recent filing

Nurix Therapeutics Inc Capital Reinvestment Ratio (2019–2019)

This chart tracks Nurix Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Nurix Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Nurix Therapeutics Inc (2019–2019)

Year-by-year Capital Reinvestment Ratio for Nurix Therapeutics Inc from 2019 to 2019. For live market cap and broader valuation context, see market cap of Nurix Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2019	2.75x	$601.00K	$1.65 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow